1. Home
  2. RCKT vs NVGS Comparison

RCKT vs NVGS Comparison

Compare RCKT & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • NVGS
  • Stock Information
  • Founded
  • RCKT 1999
  • NVGS 1997
  • Country
  • RCKT United States
  • NVGS United Kingdom
  • Employees
  • RCKT N/A
  • NVGS N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • NVGS Marine Transportation
  • Sector
  • RCKT Health Care
  • NVGS Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • NVGS Nasdaq
  • Market Cap
  • RCKT 1.4B
  • NVGS 1.1B
  • IPO Year
  • RCKT N/A
  • NVGS N/A
  • Fundamental
  • Price
  • RCKT $13.98
  • NVGS $16.09
  • Analyst Decision
  • RCKT Strong Buy
  • NVGS Strong Buy
  • Analyst Count
  • RCKT 9
  • NVGS 3
  • Target Price
  • RCKT $53.22
  • NVGS $22.00
  • AVG Volume (30 Days)
  • RCKT 744.0K
  • NVGS 203.3K
  • Earning Date
  • RCKT 11-07-2024
  • NVGS 11-06-2024
  • Dividend Yield
  • RCKT N/A
  • NVGS 1.24%
  • EPS Growth
  • RCKT N/A
  • NVGS 13.48
  • EPS
  • RCKT N/A
  • NVGS 1.12
  • Revenue
  • RCKT N/A
  • NVGS $564,280,000.00
  • Revenue This Year
  • RCKT N/A
  • NVGS $3.05
  • Revenue Next Year
  • RCKT $411.05
  • NVGS $2.17
  • P/E Ratio
  • RCKT N/A
  • NVGS $14.42
  • Revenue Growth
  • RCKT N/A
  • NVGS 5.99
  • 52 Week Low
  • RCKT $13.80
  • NVGS $13.85
  • 52 Week High
  • RCKT $32.53
  • NVGS $18.18
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.71
  • NVGS 56.49
  • Support Level
  • RCKT $16.65
  • NVGS $15.25
  • Resistance Level
  • RCKT $17.83
  • NVGS $16.57
  • Average True Range (ATR)
  • RCKT 0.89
  • NVGS 0.41
  • MACD
  • RCKT -0.27
  • NVGS 0.08
  • Stochastic Oscillator
  • RCKT 4.12
  • NVGS 76.85

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture).

Share on Social Networks: